Vaginal Diazepam Use With Urogenital Pain/Pelvic Floor Dysfunction

Serum Diazepam Levels and Efficacy Data

Donna J. Carrico, MS, WHNP; Kenneth M. Peters, MD


Urol Nurs. 2011;31(5):279-284. 

In This Article


The purpose of this article is to describe the serum diazepam levels and efficacy of the off-label use of vaginal diazepam for pelvic floor dysfunction pain, PBS/IC, and/or vulvar pain in a clinic population, as measured by laboratory values, clinical examination findings, and patient self-reports that included a visual analog scale for pain (0 to 10 scale) and an internally created patient home recording form (see Figure 2). Data were collected prospectively as part of this clinical practice database study, which received Institution Review Board (IRB) approval, and then pulled from the clinic's charts by the first author, also with IRB approval. This preliminary report is not designed to be part of a rigorous research trial; therefore, there is no randomization or control group.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: